SciClone Pharmaceuticals (Holdings) Past Performance
How has SciClone Pharmaceuticals (Holdings) performed over the past 5 years?
Past Performance Score4/6
Past Performance Score 4/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 6600 has high quality earnings.
Growing Profit Margin: 6600's current net profit margins (31.3%) are lower than last year (37.3%).
Past Earnings Growth Analysis
Earnings Trend: 6600's earnings have grown significantly by 22.2% per year over the past 5 years.
Accelerating Growth: 6600's earnings growth over the past year (6.9%) is below its 5-year average (22.2% per year).
Earnings vs Industry: 6600 earnings growth over the past year (6.9%) exceeded the Pharmaceuticals industry 5.2%.
Return on Equity
High ROE: 6600's Return on Equity (32.2%) is considered high.